Hagen Cramer

Company: QurAlis

Job title: Chief Production Officer

Seminars:

Unlocking Efficient Oligonucleotide Manufacturing in Line with Regulatory Expectations 3:00 pm

With RNA editing evolving as the next frontier therapeutic modality, many hurdles need Workshop Leaders: to be crossed to ensure the RNA molecules are synthesized correctly, efficiently and at scale. This puts CMC strategies and cGMP manufacturing at the heart of the challenges to be addressed before upscaling manufacturing and ensuring it is in line…Read more

day: Pre-Conference Day